Cargando…

Proteomics score: a potential biomarker for the prediction of prognosis in non-small cell lung cancer

BACKGROUND: Biomarkers based on quantitative genomics features are related to clinical prognosis in various cancer types. However, the association between proteomics and prognosis in non-small cell lung cancer (NSCLC) is unclear. Here, we developed a proteomics score for the prediction of prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Jie, Zhang, Jing, Zou, Dan, Gong, Wuxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798976/ https://www.ncbi.nlm.nih.gov/pubmed/35116940 http://dx.doi.org/10.21037/tcr.2019.08.39

Ejemplares similares

Deep neural network classification based on somatic mutations potentially predicts clinical benefit of immune checkpoint blockade in lung adenocarcinoma
por: Peng, Jie, et al.
Publicado: (2020)

Development and validation of a pyradiomics signature to predict initial treatment response and prognosis during transarterial chemoembolization in hepatocellular carcinoma
por: Peng, Jie, et al.
Publicado: (2022)

NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score
por: Song, Peng, et al.
Publicado: (2020)

LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma
por: Piao, Longzhen, et al.
Publicado: (2019)

Potentiality of forkhead box Q1 as a biomarker for monitoring tumor features and predicting prognosis in non‐small cell lung cancer
por: Li, Lan, et al.
Publicado: (2019)

Glasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysis
por: Zhu, Lucheng, et al.
Publicado: (2016)

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
por: Tang, Yong, et al.
Publicado: (2017)

The Combination of Radiotherapy With Immunotherapy and Potential Predictive Biomarkers for Treatment of Non-Small Cell Lung Cancer Patients
por: Meng, Lu, et al.
Publicado: (2021)

HEG1 as a novel potential biomarker for the prognosis of lung adenocarcinoma
por: Zou, Xin, et al.
Publicado: (2022)

Development and validation of a polygenic hazard score to predict prognosis and adjuvant chemotherapy benefit in early-stage non-small cell lung cancer
por: Li, Dan-Hua, et al.
Publicado: (2022)

Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia
por: HANAFI, Arif R, et al.
Publicado: (2020)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020)

Serum midkine as non-invasive biomarker for detection and prognosis of non-small cell lung cancer
por: Stern, Louisa, et al.
Publicado: (2021)

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer
por: Hong, Yang, et al.
Publicado: (2021)

Evaluating the Potential of T Cell Receptor Repertoires in Predicting the Prognosis of Resectable Non-Small Cell Lung Cancers
por: Song, Zhengbo, et al.
Publicado: (2020)

Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer
por: Wu, Peng, et al.
Publicado: (2022)

Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer
por: Xie, Yujiao, et al.
Publicado: (2018)

Katanin P60: a potential biomarker for lymph node metastasis and prognosis for non-small cell lung cancer
por: Wang, Lei, et al.
Publicado: (2020)

Identification of CXCL5 expression as a predictive biomarker associated with response and prognosis of immunotherapy in patients with non‐small cell lung cancer
por: Deng, Jie, et al.
Publicado: (2022)

Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer
por: Ran, Hailiang, et al.
Publicado: (2022)

SMOX expression predicts the prognosis of non-small cell lung cancer
por: Huang, Zhanghao, et al.
Publicado: (2021)

Genomic landscape and prognosis of patients with TP53-mutated non-small cell lung cancer
por: Fan, Zhisong, et al.
Publicado: (2022)

Proteomic Profiling of Small Extracellular Vesicles Isolated from the Plasma of Vietnamese Patients with Non-Small Cell Lung Cancer Reveals Some Potential Biomarkers
por: Bui, Thao Phuong, et al.
Publicado: (2022)

Deep learning to estimate durable clinical benefit and prognosis from patients with non-small cell lung cancer treated with PD-1/PD-L1 blockade
por: Peng, Jie, et al.
Publicado: (2022)

Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers
por: Wu, Xinyu, et al.
Publicado: (2023)

The potential of high-order features of routine blood test in predicting the prognosis of non-small cell lung cancer
por: Luo, Liping, et al.
Publicado: (2023)

CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer
por: Nam, Yunha, et al.
Publicado: (2022)

Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non‐small cell lung cancer receiving EGFR‐TKI treatment
por: Kasahara, Norimitsu, et al.
Publicado: (2020)

Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis
por: Gong, Ke, et al.
Publicado: (2021)

Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening
por: Wu, Yijun, et al.
Publicado: (2023)

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
por: Li, Zhenling, et al.
Publicado: (2015)

A Radioresponse-Related lncRNA Biomarker Signature for Risk Classification and Prognosis Prediction in Non-Small-Cell Lung Cancer
por: Song, Jiahang, et al.
Publicado: (2021)

Ferroptosis in Non-Small Cell Lung Cancer: Progression and Therapeutic Potential on It
por: Zou, Jiayu, et al.
Publicado: (2021)

Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance
por: Pu, Xingxiang, et al.
Publicado: (2018)

Increased Expression of TAP Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer
por: Cheng, Yuanjun, et al.
Publicado: (2020)

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
por: HONG, LING-ZHI, et al.
Publicado: (2013)

Platelet count predicts prognosis in operable non-small cell lung cancer
por: YU, DANGFAN, et al.
Publicado: (2013)

Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer
por: Xia, Xin, et al.
Publicado: (2016)

Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer
por: Liu, Xingyuan, et al.
Publicado: (2019)

CCKAR is a biomarker for prognosis and asynchronous brain metastasis of non-small cell lung cancer
por: Liang, Nan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_icdd71q1pr1t45esjimhsvj17c